Global orthopedic medical device company and leader in foot care solutions. Our products are developed to correct the root problem, not merely treat the symptoms. All products are developed by surgeons with years of experience in their own practices. GraMedica® is the parent company behind HyProCure® and osteo-WEDGE(TM). GraMedica® continues to develop additional product lines to support our mission of “Changing Lives, One Step at a Time.”
Friday, August 10, 2012
Why Choose HyProCure®?
This pioneering device is placed deep into the canalis portion of the sinus tarsi, reestablishing the normal pivot over which the talus (ankle bone) glides, thereby properly realigning the foot and ankle bones and restoring normal function. HyProCure® received FDA approval on September 16, 2004. The first HyProCure® placement took place on September 22, 2004.
Learn more here>>>
Labels:
HyProCure®
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment